Catalyst Crew Technologies Corp. has retained securities attorney Brian Higley to serve as securities counsel to the company. Mr. Higley, based in Utah, advises public companies on corporate governance, securities law compliance, regulatory matters, and capital markets activities. He will assist the company with ongoing securities law compliance, regulatory filings, and other corporate legal matters. This appointment comes as Catalyst Crew Technologies continues executing its strategic transition into artificial intelligence-enabled healthcare technology. The company is focused on developing scalable digital health solutions for emerging markets, with an initial emphasis on Latin America, pursuing opportunities across telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
Mr. Higley is listed on the OTC Markets website as one of a limited group of Premium Legal Service Providers. This designation identifies experienced securities attorneys who assist public companies with regulatory compliance, disclosure matters, and capital markets activities. According to OTC Markets, only nine legal service providers are currently listed within this premium category. Maintaining strong governance and regulatory compliance is an important priority for the company, said Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp. We are pleased to work with Mr. Higley as we continue strengthening the company's legal and compliance infrastructure as a public company.
The engagement reflects the company's continued commitment to maintaining appropriate legal, governance, and regulatory compliance frameworks as it advances its strategic initiatives. For investors seeking detailed information, the company's official filings are accessible through the U.S. Securities and Exchange Commission website. This move to strengthen corporate governance infrastructure is significant for a development-stage company transitioning its business model. Catalyst Crew Technologies has not generated revenues from its newly announced AI healthcare direction and acknowledges that its securities involve a high degree of risk. The company's ability to successfully implement its business plan, secure financing, complete acquisitions, and comply with regulatory requirements remains subject to various market and economic conditions.
The appointment of premium legal counsel signals the company's recognition of the importance of robust governance structures during periods of strategic transition. As public companies in emerging technology sectors face increased regulatory scrutiny, particularly in healthcare technology, establishing strong compliance frameworks becomes essential for maintaining investor confidence and facilitating future growth initiatives. The selection of a recognized legal expert from the OTC Markets premium provider list demonstrates a proactive approach to navigating complex securities regulations while pursuing ambitious technological development in competitive healthcare markets.
